Screening program for familial hyperchylomicronemia syndrome detection: Experience of a university health system
Open Access
- 7 February 2023
- journal article
- research article
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 67 (3) , 408-415
Abstract
Objective: Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive metabolic disorder caused by mutations related to chylomicron metabolism. The objective of this study is to show the development and results of a screening program for FCS in Argentina. Materials and methods: A cross-sectional study was performed. All patients > 18 years with a triglyceride level ≥ 1,000 mg/dL in the period from January 1, 2017 to December 31, 2021 were included. The program was developed in three stages: [...] ABSTRACT Objective: Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive metabolic disorder caused by mutations related to chylomicron metabolism. The objective of this study is to show the development and results of a screening program for FCS in Argentina. Materials and methods: A cross-sectional study was performed. All patients > 18 years with a triglyceride level ≥ 1,000 mg/dL in the period from January 1, 2017 to December 31, 2021 were included. The program was developed in three stages:Keywords
This publication has 40 references indexed in Scilit:
- Describing Sequence Variants Using HGVS Nomenclature2016
- REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense VariantsThe American Journal of Human Genetics, 2016
- Mecanismos básicos: estructura, función y metabolismo de las lipoproteínas plasmClínica e Investigación en Arteriosclerosis, 2013
- Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2012
- Triglyceride associated polymorphisms of the APOA5gene have very different allele frequencies in Pune, India compared to EuropeansBMC Medical Genetics, 2006
- Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variantsClinical Chemistry and Laboratory Medicine (CCLM), 2005
- Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levelsHuman Molecular Genetics, 2002
- Apolipoprotein E Polymorphism and Cardiovascular Disease: A HuGE ReviewAmerican Journal of Epidemiology, 2002
- An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative SequencingScience, 2001
- Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein epsilon 4 allele.Journal of Clinical Investigation, 1996